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The Bj1 gene encodes the Drosophila homolog of RCC1, the guanine-nucleotide exchange factor for RanGTPase. Here, we provide the
first phenotypic characterization of a RCC1 homolog in a developmental model system. We identified Bj1 (dRCC1) in a genetic screen to
identify mutations that alter central nervous system development. We find that zygotic dRCC1 mutant embryos exhibit specific defects in the
development and differentiation of lateral CNS neurons although cell division and the cell cycle appear grossly normal. dRCC1 mutant nerve
cords contain abnormally large cells with compartmentalized nuclei and exhibit increased transcription in the lateral CNS. As RCC1 is an
important component of the nucleocytoplasmic transport machinery, we find that dRCC1 function is required for nuclear import of nuclear
localization signal sequence (NLS)-carrying cargo molecules. Finally, we show that dRCC1 is required for cell proliferation and/or survival
during germline, eye and wing development and that dRCC1 appears to facilitate apoptosis.
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Regulated macromolecular transport is a central mediator
of cell biological and developmental processes. A key
player in the transport process is RCC1 (regulator of
chromatin condensation) which mediates nucleocytoplasmic
transport, cell cycle progression, microtubule organization,
and nuclear envelope assembly in eukaryotic cells (Moore,
2001; Nishimoto, 2000). RCC1 was first identified by
Nishimoto et al. (1978) in a screen for mutations that affect
mammalian cell cycle progression. Cell lines mutant for
RCC1 display a cell cycle arrest or premature chromosome
condensation phenotype at different cell cycle boundaries.
RCC1 encodes an abundant nuclear protein that associates
with chromosomes (Ohtsubo et al., 1987) and belongs to a
class of highly conserved proteins present in all eukaryotic0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Berkeley, CA 94720.species surveyed (Bamba et al., 2002; Clark and Sprague,
1989; Nishitani et al., 1990; Uchida et al., 1990).
The first defects associated with RCC1 loss of function in
mammalian cell lines are inappropriate activation of the
p34cdc2 kinase and premature initiation of mitosis during S
phase (Nishitani et al., 1991). However, RCC1 plays many
different roles in the cell. For example, S. cerevisiae RCC1
mutations affect mating pathways (Clark and Sprague,
1989), pre-mRNA splicing (Aebi et al., 1990), mRNA 3V
end formation (Fleischmann et al., 1991), and mRNA export
(Kadowaki et al., 1992). In S. pombe, mutations in RCC1
result in cell cycle defects (Matsumoto and Beach, 1991)
similar to those in mammalian cell lines. Specifically, RCC1
promotes nuclear assembly and loss of RCC1 activity results
in post-mitotic nuclear envelope fragmentation (Demeter et
al., 1995) and nucleolar fragmentation (Kadowaki et al.,
1994). Mammalian cells mutant for RCC1 also exhibit
dramatic reorganization of ribonucleoprotein particles and
splicing factors (Huang et al., 1997) as well as a nuclear
fragmentation phenotype (Nishitani et al., 1991).
Clues as to the molecular mechanism through which
RCC1 regulates these different cellular processes arose
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associated protein in cultured cells (Bischoff and Ponstingl,
1991b). Ran is a small Ras-like GTPase that exists in two
different nucleotide-bound states and performs multiple
cellular functions by switching between these two states
(Drivas et al., 1990). In addition to its well-characterized role
in nucleocytoplasmic transport, Ran, like RCC1, promotes
microtubule polymerization and nuclear envelope assembly
(Kalab et al., 1999; Ohba et al., 1999; Zhang and Clarke,
2000). Biochemical analyses demonstrated that RCC1 func-
tions as the guanine-nucleotide exchange factor for Ran and
regulates the ratio of RanGTP to RanGDP in the nucleus
(Bischoff and Ponstingl, 1991a), thus enabling Ran to
promote nucleocytoplasmic transport and microtubule orga-
nization. Due to the highly compartmentalized nature of the
cellular processes controlled by RCC1 and Ran, the subcel-
lular localization of RCC1 is critical for its function. RCC1
protein is restricted to the nucleus during interphase and
associates with mitotic chromosomes at mitosis (Moore et
al., 2002; Trieselmann and Wilde, 2002). This ensures that a
high concentration of RanGTP is generated only within the
nuclear compartment during interphase or near the mitotic
chromosomes during mitosis, which is critical for Ran to
carry out its cellular functions.
The primary molecular tag that targets proteins to the
nucleus in eukaryotic cells is the nuclear localization signal
sequence (NLS), which mediates selective import through
the nuclear pore complex. Eukaryotic cells possess trans-
porter molecules called Importins that recognize NLS
signals and help transport various cargo into the nucleus
(Weis, 2003). In the cytosol, Importins recognize NLS
signals on cargo molecules and form the cargo complex,
which translocates into the nucleus through the nuclear
pore complex. Within the nucleus, Ran-GTP, which is
generated through the nucleotide exchange activity of
RCC1, binds to the Importin–cargo complex and releases
the cargo proteins (Rexach and Blobel, 1995). Conversely,
Ran-GTP is necessary for the binding of the export shuttle
protein Exportins and cargo in the nucleus (Fornerod et al.,
1997) to mediate nuclear export of molecules such as Yan
(Tootle et al., 2003) into the cytosol. In the cytosol, Ran
converts back to the GDP-bound form through its GTPase
activity aided by effectors like RanGAP (Bischoff et al.,
1994) and RanBP1 (Bischoff et al., 1995). To ensure the
directional transport processes occur correctly, a high Ran-
GTP/Ran-GDP ratio must be maintained in the nucleus.
The chromatin-associated RCC1 protein acting as the
guanine nucleotide exchange factor (RanGEF) is critical
to create the Ran gradient and thus regulates directional
nuclear transport.
Ran-GTP or purified RCC1 can promote microtubule
polymerization in Xenopus egg extracts (Kahana and Cleve-
land, 1999). The ability of sperm nuclei to induce mitotic
spindle formation in egg extracts also depends on chroma-
tin-tethered RCC1 to regenerate Ran-GTP (Carazo-Salas et
al., 1999). This process appears independent of nucleartransport (Salus et al., 2002) and recent work discovered
that RCC1 and Ran regulate this process through the same
effector molecules they employ during nuclear transport
(Gruss et al., 2001; Nachury et al., 2001; Wiese et al.,
2001). In the cytosol, where Ran-GTP levels are low,
Importins bind to microtubule assembly promoting factors
(TPX2, NuMA) and inhibit their ability to promote micro-
tubule assembly. In the nucleus, where RCC1 generates a
high local Ran-GTP concentration near the chromatin, Ran-
GTP binds to Importins and releases their inhibitory effect
on microtubule promoting factors. The released TPX2 and
NuMA factors then promote spindle assembly (Tsai et al.,
2003). Consistent with this, inhibition of either RCC1 or
Ran function in Caenorhabditis elegans embryos or human
cell lines disrupts spindle organization, chromosome align-
ment and segregation, and also causes various other mitotic
defects (Askjaer et al., 2002; Bamba et al., 2002; Moore et
al., 2002).
Although the function of RCC1 has been well studied in
yeast and mammalian cell lines, the requirement of RCC1
function during the development of multicellular organisms
remains largely unknown. The Drosophila RCC1 homolog,
Bj1, was cloned over 10 years ago (Frasch, 1991) but its in
vivo function during Drosophila development has not been
explored. We identified four EMS-induced alleles of Bj1 in
a genetic screen for mutations that disrupt Drosophila CNS
development. Bj1 zygotic mutants display general defects in
the development and differentiation of lateral CNS neurons.
In Bj1 mutant nerve cords, cells accumulate increased levels
of mRNA and display enlarged and compartmentalized
nuclear morphology. Some of these defects likely arise
due to defects in nucleocytoplasmic transport as we ob-
served defective nuclear import of a NLS carrying h-Gal
cargo protein in Bj1 mutant embryos. Similarly, nuclear
import may be critical for apoptosis as we observed that Bj1
dominantly suppresses hid-induced apoptosis in the Dro-
sophila eye. Finally, Bj1 also appears to be required for cell
proliferation and/or survival as Bj1 mutant germline clones
as well as Bj1 mutant eye and wing clones fail to develop.
These results provide the first description of the develop-
mental effects of Bj1 function in Drosophila.Materials and methods
Fly strains and genetics
Fly strains used include wild-type Oregon R, dRCC1FF32,
dRCC1VV179, dRCC1XX138, dRCC1UU92, dRCC1sens[837],
P{w+ mW.hs = FRT(whs)}2A, y1 w*; P{w+ m* = GAL4-ey.
H}3–8, P{w+ mC = UAS-FLP1.D}JD1/CyO; P{w+ mW.hs =
FRT(whs)}2A P{w+ mC = GMR-hid}SS3, l(3)CL-L1/TM6,
P{ry+ t7.2 = hsFLP}1, y1 w1118; P{ry+ t7.2 = Act5-FRT-Draf-
FRT-tau-lacZ}/CyO, P{w+ mC = UAS-lacZ.NZ}20b (Y. Hir-
omi and S. West, unpublished). Gene over-expression or
misexpression was achieved using the Gal4/UAS system and
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UAS-dRCC1, UAS-myc-dRCC1-c terminal deletion (UAS-
dRCC1(del)).
Clonal analysis
We employed the Act5-FRT-Draf-FRT-tau-lacZ cassette
developed by Strul and Basler (1993) to generate randomly
labeled clones in the embryo. Wild-type and dRCC1 mutant
embryos carrying the lacZ cassette and hs70-flp were aged
to 3–3.5 h, heat-shocked at 32jC for 30 min and then aged
until stage 16. Double staining was performed against h-gal
using the Vector SG kit (Vector Lab) to obtain blue
coloration followed by Even-skipped staining using stan-
dard DAB staining (Ward and Skeath, 2000). To minimize
color transformation, after Vector SG staining, embryos
were treated in 3% H2O2 for 1 h to eliminate residual
peroxidase activity.
Molecular biology
We identified molecular lesions in five dRCC1 EMS
alleles via standard PCR-based sequencing methods. For
each allele, we sequenced the entire coding region and
intron–exon boundaries from genomic DNA obtained from
homozygous mutant embryos. dRCC1FF32 contains a 15
base pair deletion from base 769 to 783 within the gene
region FBgn0002638. This results in a five amino acid
residue in frame deletion at the beginning of the second
RCC1 repeat. dRCC1VV179 contains a C to T missense
mutation at position 1714 and results in a Pro to Leu change
near the end of the fourth RCC1 repeat. dRCC1XX138
contains a large deletion from positions 1293 to 1738 and
an insertion of two adenines. This results in a frame shift at
the end of the fourth RCC1 repeat and a premature stop
codon after a run of 33 additional irrelevant amino acids.
dRCC1UU92 contains a G to A missense mutation at position
1114 and results in a Gly to Arg change in the middle of
fourth RCC1 repeat. The dRCC1sens[837] allele was identi-
fied to be an allele of dRCC1 via complementation test
(Salzberg et al., 1994). It contains a G to A change at
position 770 and results in a Gly to Glu change at the
beginning of second RCC1 repeat.
To engineer UAS-dRCC1 fly lines, full-length dRCC1
cDNA was amplified from total RNA from OreR overnight
embryos using the SuperScript RT-PCR system (Invitro-
gen). The OreR dRCC1 protein sequence differs from theFig. 1. dRCC1 mutant embryos display specific defects in lateral CNS developmen
mutant (B, D, F, H) nerve cords. (A) Eve is expressed in 9–10 EL neurons (arrow)
(arrowhead). (B) In dRCC1 mutants Eve is expressed in 3–5 EL neurons in abdom
(arrowhead). (C) In the dorsal region of the nerve cord, Eve is expressed in RP2 (arr
development is normal in dRCC1 mutant nerve cords. (E) En is expressed in lateral
the WT nerve cord. (F) In dRCC1 mutants, En expression is greatly reduced in
(arrowhead). (G) In the WT nerve cord, Zfh-1 is expressed in lateral cell clusters (
expression is reduced in lateral neurons (arrow) and appears unaffected in medialBDGP prediction sequence by three polymorphisms, in-
cluding a Ser to Arg change at the middle of the second
RCC1 repeat (amino acid residue 111), a Lys to Glu
change at position 476 and Val to Ala change at position
490, both of which are located within the dRCC1 repeats.
Full-length dRCC1 cDNA obtained was cloned into
pUAST vector and stable transformation lines were gener-
ated following standard procedures (Rubin and Spradling,
1982). To create an N-terminally Myc-tagged UAS-dRCC1
construct that lacks the Bj1 repeats and EK sequence, C-
terminally truncated dRCC1 was amplified from full-length
dRCC1 template using a primer at the boundary of the last
RCC1 repeat (amino acid residue 421) and a primer
containing a single Myc coding sequence directly preced-
ing the initiation Met.
Immunohistochemistry and confocal microscopy
Single and double immunohistochemical and immuno-
fluorescence staining and non-radioactive in situ hybridiza-
tion were performed as described previously (Skeath et al.,
1992). We used the following antibodies at the indicated
concentration: rabbit-a-eve (1:2000) (Frasch et al., 1987);
mouse-a-Bj1 (1:10) (Frasch, 1991); mouse-a-Engrailed
(1:10) (Patel et al., 1989); mouse-a-Zfh-1 (1:1000) (Lai et
al., 1991); mouse-a-BrdU (1:20; Becton Dickinson); rabbit-
a-phospho-H3 (1:1000; Upstate); rabbit-a-Lamin (1:1000)
(Smith et al., 1987); mouse-a-Lamin (1:20) (Gruenbaum et
al., 1988); mouse-a-h-Gal (1:2000; Promega); rabbit-a-h-
Gal (1:2000; Jackson); mouse-a-Myc (1:1000; Sigma).
For visualization of the dRCC1 protein during different
cell cycle phases, quick methanol fixation method was used
to preserve the subcellular localization of the protein
(Trieselmann and Wilde, 2002). Briefly, dechorionated
embryos were fixed in equal volume of methanol and
heptane for 1 min with shaking. Devitellinized embryos
were recovered from the bottom and stained with standard
immunofluorescent staining protocol. Extra care is taken to
avoid breaking the embryos as the methanol fixed embryos
are very brittle. The embryos were imaged on top of a
coverslip on an inverted confocal microscope (TCS SP2,
Leica,).
BrdU labeling experiments were performed essentially as
described in Shermoen (Sullivan et al., 2000). Overnight
embryos were labeled for 40 min in BrdU followed by
immediate fixation to avoid labeling the progeny of mitotic
cells.t. Ventral view of stage 16 wild-type (WT) (A, C, E, G) and dRCC1FF32/FF32
per abdominal hemisegment and 4–5 EL neurons per thoracic hemisegment
inal hemisegments (arrow) and 3–4 EL neurons in thoracic hemisegments
ow) and aCC/pCC (arrowhead). (D) RP2 (arrow) and aCC/pCC (arrowhead)
cell clusters (arrow) and additional more medial cell clusters (arrowhead) in
the lateral clusters (arrow) but appears normal in the more medial clusters
arrow) and more medial neurons. (H) In dRCC1 mutant nerve cords, Zfh-1
regions. Anterior is to the left in all panels. Scale bar, 40 Am.
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The Drosophila RCC1 homolog Bj1 regulates lateral CNS
development
We identified Bj1 as a regulator of lateral CNS develop-
ment in Drosophila in a large scale EMS mutagenesis of the
third chromosome to screen for mutations that alter the CNS
expression pattern of the even-skipped gene (eve). eve
encodes a homeodomain protein that regulates neuronal fate
and marks a specific population of neurons (Doe et al.,
1988). In wild-type stage 16 Drosophila nerve cords, Eve is
expressed in 20 cells per abdominal hemisegment, including
the well-characterized aCC/pCC, RP2, and U neurons in the
medial and intermediate regions of the CNS, and 9–10 Eve
lateral (EL) neurons at the lateral edge of the nerve cord
(Figs. 1A, B, 4–5 EL neurons develop in thoracic hemi-
segments). In the screen, we identified four alleles of a
single complementation group, whose mutant phenotype is
a specific loss of EL neurons. Embryos homozygous for any
one of these alleles exhibit an approximately 50% reduction
of EL neurons with 3–5 ELs developing per abdominal
hemisegment (Fig. 1C). The pattern of all Eve-positive
medial and intermediate neurons appears unaffected in these
embryos (Fig. 1D).
In addition, we assayed the development of Engrailed
(En) and Zinc-finger homeodomain protein (Zfh-1)-express-
ing neurons, as each of these markers labels a subset of
neurons in the medial, intermediate, and lateral regions of
the CNS (Figs. 1E, G). In homozygous mutant nerve cords,
we found a strong decrease in the number of En- and Zfh-1-
positive lateral neurons, however, the pattern of En- or Zfh-
1-positive medial or intermediate neurons appears wild type
(Figs. 1F, H). These mutant embryos also exhibit morpho-
logical defects in the lateral CNS as the lateral margin of
mutant nerve cords appears rough and scalloped relative to
wild type. We interpret these data to indicate that this
complementation group regulates the development of mul-
tiple neural lineages in the lateral CNS.
To identify the molecular nature of this gene, we used
deficiency mapping to localize it to polytene chromosomal
region 64–66. Within this region, we identified one P-
element line EP3630 that fails to complement all four
EMS alleles and exhibits the same lateral CNS phenotype.
EP3630 contains a P-element insertion in the 5V UTR region
of Bj1, the Drosophila RCC1 homolog. Excision of the P-
element reverts the lethality of the P-element and the
associated CNS mutant phenotype, suggesting the P-ele-Fig. 2. Genetic identification of dRCC1. (A) Protein sequences of D. melanogas
sequence), Anopheles RCC1 and human RCC1 aligned using the Clustal W algorit
crystal structure of human RCC1 (Renault et al., 1998). The C-terminal EK-like d
molecular lesions of five dRCC1 EMS alleles are indicated in bold. (B–E) Stage 1
nerve cords Eve is expressed in 9–10 ELs (arrow). (C) In dRCC1FF32 embryos,
dRCC1 (D) or of a truncated version of dRCC1 (dRCC1-del) that deletes all codi
CNS phenotype (arrows, D, E). Anterior is to the left.ment insertion causes the CNS phenotype. To confirm that
our mutations identify Bj1, we sequenced the coding region
of Bj1 in our four EMS alleles as well as a fifth allele
identified by Salzberg et al. (1994) and identified molecular
lesions in each of them (Fig. 2A). Each mutation appears to
be a strong loss of function mutation as embryos homozy-
gous for each EMS allele as well as embryos trans-hetero-
zygous for each EMS allele over Df(3L)ZN47, ry[506],
which deletes the chromosomal region between 64C and
65C that contains Bj1 (65A), display essentially identical
lateral CNS phenotypes.
To verify correspondence between our mutant phenotype
and Bj1, we assayed if generalized expression of Bj1 in the
CNS can rescue the mutant CNS phenotypes of our com-
plementation group. We found that expressing Bj1 via the
Gal4/UAS system throughout the CNS of homozygous
mutant embryos using the Scabrous-Gal4 driver fully res-
cued the Eve CNS phenotype (Fig. 2D) as well as the
morphological defects in the nerve cord of these embryos.
Thus, we conclude that mutations in Bj1 are responsible for
the observed lateral CNS phenotype.
Bj1 was first identified by Frasch (1991) via expression
cloning. Bj1 is the only RCC1 homolog identified to date in
the Drosophila genome. For simplicity, from this point on,
we refer to Bj1 as dRCC1. RCC1 is conserved in all
eukaryotic species examined and has a consensus structure
of a basic N-terminal domain followed by seven RCC1
repeats (Fig. 2A). The N-terminal domain is sufficient to
bind DNA by itself, but is not required for RCC1 function in
mammalian cell lines (Seino et al., 1992) or for in vivo
chromatin binding (Nemergut et al., 2001). RCC1 repeats
consist of roughly 50 amino acid residues and fold into anti-
parallel h-sheets. The seven h-sheets stack together to form
a ring like structure called the h-propeller (Renault et al.,
1998), the common motif for G proteins. This structure is
thought to perform all known functions of RCC1.
Drosophila dRCC1 exhibits 40% and 29% identity,
respectively, to human and yeast RCC1 homologs within
the N-terminal domain and the RCC1 repeats. In addition to
these conserved domains, the C-terminal domain of dRCC1
includes three Bj1 repeats and one EK stretch (Frasch, 1991)
not conserved in vertebrate RCC1 homologs. To investigate
whether these C-terminal sequences are unique features of
dRCC1, we identified a single RCC1 homolog from each of
two related insect species, D. pseduoobscura and Anopheles
gambiae, through database searches (Fig. 2A). All three of
these genes contain the evolutionarily conserved N-terminal
domain and RCC1 repeats as well as additional sequencester dRCC1, D. pseduooboscura RCC1 (putative predication from genomic
hm. The seven RCC1 repeats are indicated in yellow boxes according to the
omain is indicated in blue. The three Bj1 repeats are marked in green. The
6 nerve cords of the indicated genotypes stained for Eve protein. (B) In WT
Eve is expressed in 3–5 ELs (arrow). Overexpression of either full-length
ng region after the last RCC1 repeat (E) completely rescue the dRCC1 Eve
Fig. 3. Expression dynamics of dRCC1 protein. WT (A–F, J, K) and dRCC1 mutant (G– I) embryos labeled for dRCC1 protein (A–I, K) and double-labeled
for dRCC1 and Lamin (J). During pre-syncytial and syncytial stages (A, B) dRCC1 localizes to the nucleus of all cells. (C) At stage 9, dRCC1 is expressed
ubiquitously throughout the embryo and localizes to the nucleus of all cells. (D) At stage 13, dRCC1 protein levels remain high in the CNS but decrease in all
other tissues. (E, F) In stages 14 and 16 nerve cords dRCC1 protein is highly expressed in the CNS. (G) In dRCC1FF32 mutants dRCC1FF32 protein is expressed
in some CNS cells but is largely absent from medial region of the CNS. (H) dRCC1FF32 protein is expressed predominantly in lateral regions of the CNS during
stage 16 and in enlarged cells with altered nuclear morphology. (I) High magnification view of the enlarged cells. These cells accumulate high levels of mutant
nuclear dRCC1 protein and the nuclei appear highly fragmented. (J, K) Methanol fixation of WT stage 4 syncytial embryos. (J) At interphase, dRCC1 protein
(green) is expressed exclusively in the nucleus; Lamin (red) labels the nuclear envelope. (K) During mitosis, dRCC1 colocalizes with the mitotic chromosome
and forms spindle-like structures. Scale bar, 40 Am (H), 10 Am (I).
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homologs. However, these C-terminal sequences do not bear
significant similarity to each other. Thus, the Bj1 repeats
and EK stretch in dRCC1 appear to be a recent evolutionary
addition.
To assay whether the C-terminal domains of dRCC1
provide any function during Drosophila development, we
generated a version of dRCC1 that truncates the protein after
the last RCC1 repeat and placed it under UAS control (see
Materials and methods). In dRCC1 mutant embryos, we
found that expression of this truncated version of dRCC1
rescues the dRCC1 mutant phenotype as effectively as full-
length dRCC1 (Fig. 2E). Thus, the Bj1 repeats and EKstretch C-terminal sequence appear dispensable for dRCC1
function in Drosophila neurogenesis. However, it remains
formally possible that these domains carry out other func-
tions during Drosophila development.
dRCC1 protein localizes to the nucleus and colocalizes with
mitotic chromosomes
To investigate the function of dRCC1 during Drosophila
CNS development, we examined the expression pattern of
dRCC1 protein during embryogenesis using a dRCC1-
specific antibody (Frasch, 1991) generated against the Bj1
repeats and EK stretch sequence. Pre-syncytial and syncytial
stage embryos exhibit ubiquitous expression of nuclearly
localized dRCC1 (Figs. 3A, B), indicating that dRCC1 is
supplied to the embryo maternally. dRCC1 protein exhibits
largely ubiquitous nuclear expression through stage 13.
During stage 13, when cell division ceases in non-neural
tissues, dRCC1 protein levels decrease in non-CNS cells
(Fig. 3D). From this stage on, dRCC1 is ubiquitously and
strongly expressed only in the CNS (Figs. 3E, F). Interest-
ingly, the maternal contribution of dRCC1 persists until the
end of embryogenesis as we can detect low levels of dRCC1
protein throughout the CNS of late-stage embryos homozy-
gous mutant for a dRCC1 deletion (data not shown). The
correlation between dRCC1 expression and cell division is
consistent with dRCC1 regulating the cell cycle as observed
for RCC1 in yeast and mammalian cells (Matsumoto and
Beach, 1991; Nishimoto et al., 1978).
Yeast and mammalian RCC1 homologs have been shown
to regulate mitotic spindle formation via an association with
mitotic chromosomes. To explore whether dRCC1 plays a
similar role in Drosophila, we assayed whether dRCC1
localizes to mitotic chromosomes in syncytial embryos.
Standard formaldehyde fixation methods disrupt the local-
ization of many cytoskeleton proteins within the cell (MillerFig. 4. dRCC1 mutants exhibit increased mRNA levels in the lateral CNS.
Stage 16 WT (A, C, E, G) and dRCC1FF32 mutant (B, D, F, H) embryos
labeled for cyclinA, string, dRCC1, and Ran mRNAs. (A) In stage 16 WT
nerve cords, cyclinA (cycA) mRNA is expressed at low levels in small lateral
cell clusters. (B) In stage 16, dRCC1 mutant nerve cords, cycA is expressed
at high levels in many cells throughout the lateral domain. (C) In stage 16,
WT CNS, string mRNA is expressed at low levels in the lateral cell clusters
as well as in some medial cells. (D) In dRCC1mutants, string is expressed at
high levels throughout the lateral region of the nerve cord. (E, G) In WT
nerve cords, dRCC1 (E) and Ran (G) mRNA exhibit weak expression in the
lateral CNS. In dRCC1 mutants, dRCC1 (F) and Ran (H) exhibit significant
upregulation of their mRNA expression levels in the lateral CNS. In A, C, E,
and G, the WT in situ patterns are from heterozygous or WT embryos taken
from the same in situ hybridization preparation as the corresponding dRCC1
mutant embryos shown in B, D, F, and H. As such, these embryos serve as
internal controls. (I) High magnification view of the neuroectoderm of a
stage 10 WT embryo. Dot-like structures (white arrow) highlight nascent
transcripts of string in some nuclei. (J) High magnification view of stage 15
dRCC1FF32 mutant CNS. One nascent transcription dot (arrow) is detected
in a string-positive cell. Nuclear accumulation of string mRNA in dRCC1
mutant nerve cords often makes the transcriptional dots hard to identify.
Anterior is to the left. Scale bar, 40 Am (H), 5 Am (J).
Fig. 5. dRCC1 does not affect the overall cell cycle pattern in the CNS. Stage 15 WT (A, C) and dRCC1FF32 mutant (B, D) nerve cords labeled for BrdU
incorporation (A–D) and phospho-Histone-3 staining (E, F). (A, C) In the ventral (A) and dorsal (C) WT CNS, DNA synthesis occurs predominantly in cells in
the lateral regions but also at lower levels in cells found in intermediate and medial regions. (B, D) In dRCC1 mutants, the pattern of cells undergoing DNA
synthesis is disrupted, however, the overall number of cells in S-phase remain roughly the same. B and D show a ventral and dorsal view of the same nerve
cord. (E) In WT CNS, cells undergoing M phase are distributed in medial, intermediate, and lateral regions. (F) In the dRCC1 mutant CNS, the pattern and
number of cells in M-phase is roughly the same as in WT. Anterior is to the left.
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methanol fixation protocol (Trieselmann and Wilde, 2002)
to maintain the integrity of cytoskeletal proteins in Dro-
sophila embryos. Using this method, we observed that
dRCC1 protein localizes exclusively in the nucleus at
interphase (Fig. 3J). During mitosis, after nuclear envelope
breakdown, dRCC1 localizes with the mitotic chromosomes
and forms spindle-like structures (Fig. 3K). The ability of
dRCC1 to localize with mitotic chromosomes during cell
divisions is consistent with it regulating chromosome dy-
namics during mitosis as observed for RCC1.
We also examined the expression pattern of dRCC1
protein in dRCC1 missense mutations, which produce
mutant forms of dRCC1 protein that are recognized by the
dRCC1-specific antibody. Cells in the medial and interme-
diate regions of dRCC1 mutant nerve cord are largelydevoid of dRCC1 protein. However, in the lateral regions,
dRCC1 protein appears to be upregulated most notably in
enlarged cells that express high levels of nuclear dRCC1.
The nuclear morphology of these cells appears disrupted
(Fig. 3I). Instead of a homogenous staining pattern as in
wild type, the nuclei of these cells appear speckled. Several
large granules form within the nucleus and divide the
nucleus into several compartments. This phenotype is sim-
ilar to the RCC1 nucleolar fragmentation phenotype in
mammalian cell lines (Kadowaki et al., 1994).
dRCC1 regulates the development and differentiation of
lateral CNS neurons
Our analysis of dRCC1 mutants indicates that the CNS
phenotype is largely restricted to lateral neurons. This
Fig. 6. dRCC1 does not affect cell number in the neuroblast 3-3 (NB 3-3) lineage. WT (A–C) and dRCC1FF32 mutant (D–F) embryos stained for Eve (dark
gray) and h-Gal (brown). A–C and D–F show consecutive focal planes of the same NB3-3 clone to visualize all cells within each clone. (A–C) AWT NB 3-3
clone contains 9–10 EL neurons that express Eve in the nucleus and one large motor neuron that does not express Eve and is in the lateral region of the clone
(arrow). The ELs send an axon bundle across the midline and projecting anteriorly (arrowhead). (D–F) A dRCC1 mutant NB 3-3 clone contains approximately
the same number of cells as in WT, but many neurons fail to express Eve (arrowhead). The large motor neuron (arrow) appears to form normally based on its
size and relative position within the clone. Anterior is to the left. Scale bar, 20 Am.
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regulatory mechanisms that control lateral CNS develop-
ment remain poorly understood (Skeath, 1999). Based on
this phenotype and the known role of RCC1 homologs in
cell cycle regulation, we assayed for cell-cycle defects using
cyclinA (cycA), B, E, and cdc25/string in the CNS. In stage
16 wild-type nerve cords, cycA mRNA and CycA protein
are expressed at low levels in small clusters of cells in the
lateral and intermediate regions of the nerve cord (Fig. 4A,
not shown). In dRCC1 mutant nerve cords, cycA mRNA and
protein expression exhibit wild-type levels of expression in
the medial and intermediate regions of the CNS but aber-
rantly high levels of expression in the lateral region (Fig.
4B). We observed similar alterations to the expression
patterns of the cyclin-kinase string (Figs. 4C, D) as well
as cycB and cycE (data not shown). Interestingly, we alsofound that the mRNA expression pattern of dRCC1 as well
as its effector gene Ran displayed a similar lateral-specific
increase in transcript accumulation in dRCC1 mutants (Figs.
4E–H). These data suggest that loss of dRCC1 function
leads to a general increase in the expression of cell cycle
genes as well as dRCC1 and Ran in the lateral region of the
CNS. To test whether this increase in mRNA level is a
general phenomenon or largely restricted to cell cycle-
related genes, we examined the expression pattern of
Hel25 and snRNP70K. Hel25 is an RNA helicase involved
in mRNA processing and export, and snRNP70K encodes
the U1 small nuclear ribonucleoprotein particle 70k protein.
Both are ubiquitously expressed in the CNS of late stage
embryos and neither appear to be differentially regulated
during the cell-cycle. In dRCC1 mutant nerve cords, Hel25
and snRNP70K are expressed in their normal wild-type
Fig. 7.
Fig. 8.
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does not lead to a general upregulation of all genes but
rather preferentially affects those that are regulated through
the cell-cycle. Thus, the general transcriptional upregulation
of cell cycle genes as well as other genes in the lateral CNS
likely underlie some of the defects we observe in the
development of lateral CNS neurons.
The above experiments indicate that loss of dRCC1
results in increased accumulation of transcripts in the lateral
CNS. To distinguish whether heightened transcript accumu-
lation arises due to a decrease in mRNA turnover only or as
a result of increased transcriptional activity, we used in situ
hybridization to detect nascent transcripts in interphase
nuclei in wild-type and dRCC1 mutant embryos. In Dro-
sophila and mammalian cells, in situ hybridization com-
monly detects local accumulation of nascent transcripts
called transcriptional dots (Lawrence et al., 1989; Shermoen
and O’Farrell, 1991). We used the relative presence of
transcriptional dots to determine whether increased tran-
scriptional activity accounts for the specific lateral increase
in mRNA levels. In wild-type stage 10 embryos, we
routinely detect transcriptional dots for string mRNA (Fig.
4I), demonstrating the resolution of this detection method is
sufficient to reveal the transcriptional activity of the string
gene. By stage 14, the wild-type expression of string is low
and restricted to a few lateral cells in the nerve cord and we
were unable to detect transcriptional dots in these cells (not
shown). In contrast, we were able to detect transcriptional
dots of string in dRCC1 mutant nerve cords during stage 14
(Fig. 4J). Thus, the increase in mRNA levels in the lateral
CNS in dRCC1 mutants appears to arise at least in part due
to increased transcriptional activity.
The upregulation of cell cycle genes in dRCC1 mutant
nerve cords led us to assay for mitotic defects in dRCC1
mutant embryos. We used BrdU to label cells undergoing S-
phase and anti-phospho-histone H3 (a-PH3) antibody to
mark cells at M-phase. In wild-type stage 16 nerve cords,
BrdU labels lateral clusters of cells as well as cells in the
intermediate and medial regions of the CNS (Figs. 5A, C).
In dRCC1 mutant nerve cords, the segmentally repeated
pattern of lateral clusters of BrdU-labeled cells is disorga-
nized and we observed a slight increase of BrdU-positive
cells along the lateral edge of the CNS (Fig. 5B). In the
medial and intermediate regions of dRCC1 mutant nerve
cords, the pattern of BrdU cells also appeared disrupted
compared to wild type, but the cell numbers are not
significantly changed (Fig. 5D). Using a-PH3 as a mitoticFig. 7. dRCC1 is required for nuclear import. (A) NLS-h-Gal (green) localizes excl
driven throughout the CNS under the control of the Scabrous-Gal4 (Sca-Gal4) driv
h-Gal localizes almost exclusively to the cytoplasm of stage 15 dRCC1 mutant
Anterior is to the left. Scale bar, 20 Am.
Fig. 8. dRCC1 mutants dominantly suppress hid-induced apoptosis. (A) WT contr
ommatidia or bristles. All adult tissue arises from cells homozygous for the WT FR
and few pigment cells and bristles. (C) A dRCC1FF32 mutant eye is greatly red
dRCC1XX138 heterozygous eye is significantly larger than GMR-hid/TM6 eyes (Bmarker, we identified a small number of mitotic cells in the
medial, intermediate, and lateral regions of the wild-type
stage 16 nerve cord (Fig. 5E). In dRCC1 mutant nerve
cords, the pattern and number of a-PH3-positive cells does
not appear to differ significantly from that of wild-type
nerve cords (Fig. 5F). Our BrdU labeling and a-PH3 data
suggest that dRCC1 mutation does not significantly affect
cell division patterns in the CNS.
The lack of gross cell cycle defects in dRCC1 mutants
suggests the loss of marker gene expression in lateral
neurons could arise as a result of either defects in the
differentiation of these neurons or their absence. To
address this question, we used clonal analysis to assay
cell number in an individual lateral NB lineage. We focus
on the neuroblast 3-3 (NB3-3) lineage (Schmid et al.,
1999; Schmidt et al., 1997) because the well-characterized
EL neurons develop in this lineage and dRCC1 regulates
EL development (Fig. 1). We employed the FLP-out FRT
system designed by Struhl and Basler (1993) to generate
randomly labeled cell clones in the CNS and screened for
NB3-3 clones via Eve expression. In wild-type NB3-3
clones, we observe 9 Eve-positive cells which extend their
axons across the midline and project anteriorly and one
large Eve-negative cell that resides at the lateral region of
the clone (Figs. 6A–C). In dRCC1 mutant embryos, NB3-
3 clones (n = 2) produce roughly the same number of cells
as in wild type (Figs. 6D–F), indicating that in this
lineage, dRCC1 does not affect cell number. The loss of
Eve expression in some EL neurons indicates that dRCC1
regulates the differentiation of these neurons. However, we
were unable to obtain a clearly labeled axonal projection
pattern in mutant clones, inhibiting our analysis of axono-
genesis in dRCC1 mutants. Based on these data, we
conclude that the dRCC1 loss of EL neuron phenotype is
due to defects in EL differentiation. The general decrease
in lateral marker gene expression in dRCC1 mutant nerve
cords likely also arises from defects in neuronal differen-
tiation rather than a loss of neurons.
dRCC1 regulates nucleocytoplasmic transport
Nuclear transport employs the importins and exportins
as molecular shuttles across the nuclear envelope and
requires RCC1-Ran and Ran-GAP to facilitate nuclear
cargo release and export. An ectopically expressed domi-
nant negative form of Drosophila Importin-h blocks
nucleocytoplasmic transport and other developmental pro-usively to the nucleus of all cells in stage 15 WT nerve cords. NLS-h-Gal is
er line. The nuclear envelope is labeled with Lamin antibody (red). (B) NLS-
nerve cords in which NLS-h-Gal is expressed in the CNS via Sca-Gal4.
ol eye contains well-organized ommatidia structures and a few misoriented
T2A chromosome. (B) A GMR-hid/TM6 control eye contains no ommatidia
uced in size and contains few disorganized ommatidia. (D) A GMR-hid/
). Anterior is to the left and dorsal is up. Scale bar, 100 Am.
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mutant form of Ran that cannot hydrolyze GTP blocks
nuclear import of NLS-GFP in Drosophila embryos
(Kumar et al., 2001). The identity of dRCC1 as the
Drosophila RCC1 gene suggests that it regulates nucleo-
cytoplasmic transport. To assay if dRCC1 regulates nuclear
import in vivo, we followed the subcellular localization of
a LacZ transgene that carries the SV40 NLS signal (NLS-
h-Gal) (Hiromi and West, unpublished) in wild-type and
dRCC1 mutant backgrounds. In wild-type nerve cords, we
detected NLS-h-Gal exclusively in the nucleus (Fig. 7A),
suggesting at steady state that the SV40 NLS signal
efficiently directs most, if not all, cargo molecules into
the nucleus. Conversely, in dRCC1 mutant nerve cords, the
NLS-h-Gal is excluded from the nucleus and localizes
predominantly to the cytoplasm (Fig. 7B). Thus, dRCC1
function is essential for nuclear import of NLS-carrying
cargo proteins in Drosophila.
dRCC1 is required for cell proliferation or cell survival
during adult tissue development
The above work demonstrates a clear requirement for
zygotic dRCC1 in nucleocytoplasmic transport and in the
development of lateral CNS neurons. However, the pres-
ence of maternal dRCC1 likely masks requirements for
dRCC1 during embryogenesis. As RCC1 regulates many
cellular processes, we assayed the requirement of dRCC1
in other tissues during Drosophila development. We first
examined the function of maternal dRCC1 during em-
bryogenesis by creating dRCC1 germline clones. dRCC1
germline clones fail to develop, indicating that dRCC1
plays an essential role during oogenesis. This is consistent
with expression of dRCC1 in the ovary (Frasch, 1991).
We also generated somatic dRCC1 mutant clones in wing
and eye imaginal discs. We only recovered dRCC1 mutant
clones of five cells or less, despite routine generation of
wild-type twin spot clones of hundreds of cells. Thus,
dRCC1 appears to be required for cell proliferation and/or
survival.
dRCC1 mutants repress ectopic apoptosis induced by hid
overexpression
To follow the development of an adult tissue devoid of
dRCC1 function, we used the eGUF/hid system (Stowers
and Schwarz, 1999) to create Drosophila eyes composed
entirely of dRCC1 mutant cells (wild-type cells are elimi-
nated by the cell death gene hid driven by the GMR
promoter). In wild-type control animals, normal-sized eyes
form from cells homozygous for the otherwise wild-type
FRT2A chromosome (Fig. 8A). In control GMR-hid eyes,
all photoreceptors are missing and the eye consists of small
numbers of bristles and pigment cells (Fig. 8B). In eyes
derived from dRCC1 homozygous cells, the majority of
photoreceptors fail to develop and the eye is reduced in size,although a few disorganized ommatidia still form (Fig. 8C),
consistent with a general role for dRCC1 in cell proliferation
and/or survival. In the course of these experiments, we
fortuitously determined that our stronger dRCC1 alleles
(XX138, FF32) dominantly suppress the GMR-hid eye
phenotype (Compare Figs. 8B to D). The ability of multiple
dRCC1 alleles to suppress the hid-induced cell death phe-
notype in a dominant manner suggests that dRCC1 may
normally promote apoptosis thru the nuclear transport of
one or more apoptotic factors.Discussion
In this work, we identified and characterized the expres-
sion and function of dRCC1 during Drosophila embryonic
development. dRCC1 localizes predominantly to the nucleus
during interphase and associates with mitotic chromosomes
during mitosis. In dRCC1 mutant nerve cords, we observed
specific defects to the differentiation of lateral neurons. This
defect does not appear to arise as a result of gross defects to
cell division as mitotic patterns appear relatively normal in
dRCC1 mutants. However, we do observe a general increase
in the transcription of cell cycle and other genes in the lateral
CNS in dRCC1 mutants and it is possible that this defect
underlies this lateral neuron phenotype. We also showed that
dRCC1 regulates nucleocytoplasmic transport as dRCC1
mutant embryos exhibit a block in the nuclear import of
NLS-tagged cargo molecule. In addition, clonal analysis in
the germline and adult tissues identifies a general require-
ment of dRCC1 in cell proliferation and/or cell survival. Our
results identify dRCC1 as an essential gene for Drosophila
development and show that it plays conserved as well as
novel roles relative to the known functions of RCC1 homo-
logs in yeast and mammalian cell lines.
dRCC1 mutants exhibit defects that are largely restricted to
the lateral CNS
The phenotypes we observe in dRCC1 mutant embryos
are largely restricted to the lateral region of the CNS. These
phenotypes include a failure in the proper differentiation of
lateral neurons as well as an apparent increase in the
transcription of cell cycle and other genes. However, our
experiments on nuclear import indicate that dRCC1 is
required throughout the CNS to promote nucleocytoplasmic
transport. We can envision two non-mutually exclusive
possibilities to explain the specific lateral CNS phenotype.
One, dRCC1 performs a unique function in the lateral CNS
unrelated to nucleocytoplasmic transport. However, the
ubiquitous expression pattern of dRCC1 as well as the
general cell biological events it controls argue against this
model. Two, the lateral CNS phenotype arises because of a
characteristic unique to the lateral region of the CNS.
Consistent with this model, cell division continues in the
CNS well after it has finished in the rest of the embryo.
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cell division is more pronounced in the lateral region of CNS
(Fig. 5). Continued cell proliferation in the lateral CNS
together with large stores of maternal dRCC1 protein may
collaborate to produce specific defects in lateral neuron
differentiation. For example, maternal dRCC1 protein may
promote relatively normal development in non-neural cells
that undergo few mitoses. Since continued cell division
appears most pronounced in the lateral region of the CNS,
we might expect to observe a phenotype such as defects in
neuronal differentiation specific in this domain.
dRCC1 regulates transcriptional levels
In the dRCC1 mutant CNS, we detect a specific and
dramatic increase in the mRNA levels of many cell cycle-
regulated genes; this phenotype is most pronounced in the
lateral region. This observation partially contrasts with
previous work on RCC1 on mammalian cell lines and
yeast. In RCC1 mutant mammalian cells grown at restric-
tive temperature, the mutant RCC1 protein is rapidly lost
(Nishitani et al., 1991), and little change appears to occur to
transcriptional and pre-mRNA splicing activities (Huang et
al., 1997). Conversely, the yeast RCC1 mutant prp20
exhibits a general decrease in the steady-state mRNA levels
at non-permissive temperature (Aebi et al., 1990). At
present, it is unclear why RCC1 appears to exhibit three
distinct effects on mRNA levels in three different systems.
It is possible that the broad range of cell activities RCC1
regulates underlies the defects in mRNA levels in different
systems. For example, the association of RCC1 with DNA
might be required to regulate chromatin structure and loss
of RCC1 might lead to a predictable change in transcription
regardless of the system. However, this effect might be
counterbalanced to different degrees in different systems
thru RCC1’s roles in nucleocytoplasmic transport. For
example, if RCC1 promotes the import of one or more
factors that govern transcription of cell cycle-regulated
genes in one system but not others, this would lead to
distinct transcription effects in this system. Future work
that addresses the molecular basis of transcriptional upre-
gulation in Drosophila should help resolve how RCC1
differentially regulates mRNA levels in three different
systems.
Possible role of nucleocytoplasmic transport in dRCC1
mutant phenotype
The defect in neuronal differentiation in the lateral CNS
is the most dramatic developmental phenotype we ob-
served in dRCC1 mutants, while the block in nucleocyto-
plasmic transport is the most dramatic cell biological
phenotype. Based on these data, we speculate that the
defects in lateral neuronal differentiation may arise as a
result of block in nucleocytoplasmic transport. During the
development of the CNS, distinct profiles of transcriptionalfactors and signaling molecules must be transported into
the nucleus to activate downstream genes and direct
neuronal fate and differentiation. In dRCC1 mutants, the
nuclear import of one or more of these factors may be
disrupted and the neuronal differentiation may fail. A clear
future challenge is to determine definitively whether the
lateral neuron phenotype arises due to a defect in nucle-
ocytoplasmic transport. If so, it will be important to
identify the precise molecular targets that require dRCC1
to shuttle in and out of the nucleus to promote proper
neuronal differentiation.
In addition to the neuronal differentiation defects in
dRCC1 mutants, our observation that a reduction in dRCC1
activity dominantly suppresses the GMR-hid cell death
phenotype suggests a possible role for dRCC1 in apoptosis.
Consistent with this, activated forms of caspases are known
to translocate into the nucleus to execute apoptotic cell
death (Porter, 1999). Furthermore, nuclear translocation is
functionally important as inhibition of nuclear localization
of caspase-1 suppresses cell death (Fankhauser et al., 2000).
Thus, it is intriguing to speculate that dRCC1 may promote
cell death by mediating nuclear transport of caspases during
programmed cell death in Drosophila.
In conclusion, our work provides the first functional
analysis of a RCC1 homolog in a developmental model
system. Although dRCC1 is an essential gene, mutations
in dRCC1 produce different developmental defects in
different tissues or cell types in Drosophila. This suggests
that different cellular pathways respond in distinct ways to
the loss of dRCC1 activity and that nuclear import or
export of one or more factors may often be a critical step
during the development of a particular cell type or
developmental event. For example, in the Drosophila
Segregation Distorter system, a minor disruption in the
nuclear RanGTP gradient affects spermatogenesis but
apparently no other developmental event (Kusano et al.,
2003). The identification of dRCC1 mutations as well as
the potential to generate conditional alleles of dRCC1
should allow one to investigate dRCC1 function in a wide
variety of developmental environments and stages. Such a
systematic analysis of dRCC1 function should help illu-
minate how regulated nucleocytoplasmic transport pro-
motes different cellular outcomes and events during
multicellular development.Acknowledgments
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